GLP-1 RAs show cardiovascular benefits beyond weight loss
Browse by category
AP39 compound delivers hydrogen sulfide directly to mitochondria cells induces weight loss
Tirzepatide results in greater weight loss in women than men
Strong relationship between the increase in metabolic activity caused by once-daily GLP-1 and the amount of weight lost
LOWS study to investigate oxygen and weight status
Most Americans do not use GLP-1s long enough to see meaningful weight-loss
Allurion reveals data showing lean mass gains in patients experiencing 14% weight loss
Specialised weight navigation programme increases a patient’s chances of receiving at least one evidence-based weight-management treatment and resulted in more weight loss
LSG: The balance between superior weight loss and preventing the onset of reflux
The hidden effects of weight loss: A deep dive into the psychological impact